Skip to main content

Table 1 Demographic characteristics of nosocomial bacteremia patients infected with high MIC or low MIC MRSA

From: Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: Mortality analyses and the impact of vancomycin, MIC = 2 mg/L, by the broth microdilution method

Characteristic

Vancomycin MIC < 2 N = 97 Number of patients (%)

Vancomycin MIC = 2 N = 26 Number of patients (%)

p-valuea

p-valueb; OR (95% CI)

Elderly (>65 years old)

66 (68.0)

13 (50.0)

0.088

 

Age

70.32 ± 14.1

63.6 ± 18.0

0.250

 

Sex: male

68 (70.1)

14 (53.8)

0.118

0.04; 0.33 (0.11-0.95)

Diabetes

70 (72.2)

17 (65.4)

0.500

 

Cancer

30 (30.9)

11(43.2)

0.349

 

Congestive heart failure

14 (14.4)

4(15.4)

1.000

 

End stage renal disease

10 (10.3)

4 (15.4)

0.492

 

Liver cirrhosis

11 (11.3)

3 (11.5)

1.000

 

Cerebrovascular disease

24 (24.7)

3 (11.5)

0.188

 

Bedridden

24 (24.7)

7 (26.9)

0.804

 

Recent surgery

24 (24.7)

3 (11.5)

0.188

0.018; 0.15 (0.03-0.73)

Recent cardio-thoracic surgery

13 (13.4)

1 (3.8)

0.297

 

Hospitalization days before bacteremia

22.6 ± 10.1

23.7 ± 8.0

0.207

 

ICU admission before bacteremia

40 (41.2)

17 (65.4)

0.028

0.005; 4.83 (1.61-14.50)

Hospitalization > 2 months before bactermia

17 (17.5)

10 (38.5)

0.022

0.011; 4.56 (1.41-14.73)

Hospitalization > 1 month before bacteremia

41 (42.3)

15 (57.7)

0.187

 
  1. a: p-value calculated using a χ2 test or Fisher's exact test
  2. b: p-value as determined by logistic regression.